Dear Friends and Colleagues,
My heartiest greetings to all of you!
I would like to start by thanking the APAAACI Board of Directors, Committee Chairs and members, International advisors, faculties and National Member Societies for their valuable contributions, collaborations and collective efforts for the specialty and our delegates.
We have an exciting line up of activities to look forward to. Most notably, Prof. Rommel Lobo, President, PSAAI and I would like to invite you to join us at the APAAACI 2022 Congress PSAAI@50 that will take place in Manila from 5-8 December this year.
The theme of the Congress is ‘Evidence Based Integrated Care in Allergy, Asthma and Immunology: The New Frontiers’. More details here
The Congress will be jointly hosted by APAAACI and the Philippine Society of Allergy Asthma and Immunology (PSAAI). With a greater element of prestige, it will also be a golden jubilee celebration of the PSAAI.
APAAACI invites you to submit your abstracts, and make sure not to miss the submission deadline of 15th September 2022;
Click here, to submit your abstract.
We also encourage you not to miss the early registration deadline,
We look forward to seeing you in Manila!
EAACI & APAAACI Joint Symposium 2022
Once again APAAACI collaborated with EAACI at the EAACI 2022 in Prague with the EAACI & APAAACI joint symposium on ‘Prevention and novel treatment strategies for allergic diseases; role of Probiotics, prebiotics and OIT’.
With a fully packed room and an active discussion the speakers comprised of Prof. Ruby Pawankar (Japan), Prof. Jiu Yao Wang ( Taiwan) and Prof. Mimi Tang( Australia). he Congress was an outstanding success with 4,500 in-person attendees and 4000+ online. Hearty Congratulations to the EAACI leadership!
Please check out APAAACI virtual booth video link for a short intro of our activities;
PSAAI National Allergy Day 2022
The PSAAI National Allergy Day is targeted towards enhancing the awareness of the public on Allergic diseases.
APAAACI would like to extend their heartiest congratulations to PSAAI leadership, NAD organizing committee and speakers for a very successful PSAAI National Allergy Day.
APAAACI Publications Releases
Asia-Pacific Perspectives on the Second Year of the COVID-19 Pandemic: A Follow-up Survey : Clinical Experimental Allergy The Coronavirus disease 2019 (COVID-19) pandemic is currently in its third year. A follow-up survey was commissioned by the APAAACI Task Force on COVID-19 to compare and contrast changes in the epidemiology, clinical profile, therapeutics and public health measures of the pandemic in the Asia Pacific region.
This survey was published in Wiley Online Library by Ruby Pawankar, Bernard Yu-Hor Thong, Marysia Tiongco-Recto, Jiu-Yao Wang, Amir Hamzah Abdul Latiff, Ting Fan Leung, Philip Hei Li, Rommel Crisenio M. Lobo, Michela Lucas, Jae-Won Oh, Wasu Kamchaisatian, Mizuho Nagao,Iris Rengganis, Zarir F. Udwadia, Raja Dhar, Sonomjamts Munkhbayarlakh, Logii Narantsetseg, Duy Le Pham, Yuan Zhang, Luo Zhang. (Clin Exp Allergy 2022; 52: 965-973)
Upcoming APAAACI Publications – In Press
APAAACI is delighted to share that our paper “An online survey of clinical practice for allergic rhinitis among the Asia-Pacific representatives” is accepted for publication in Asia Pacific Journal of Allergy and Immunology (APJAI) [Impact factor: 7.1]
Ming Zheng, Xiangdong Wang, Amir Hamzah Abdul Latiff, Ashok Shah, Duy Le Pham, Dong Young Kim, Jae Won Oh, MD, Jiu Yao Wang, Kiat Ruxrungtham, Marysia Recto, Niken Lestari Poerbonegoro, Narantsetseg Logi, Sonomjamts Munkhbayarlakh, dear Ting Fan Leung, Takeshi Shimizu, Wen Chin Chiang, Wasu Kamchaisatian, Ruby Pawankar, Luo Zhang.
Thank you all for your efforts in completing the survey, in the critical evaluation of the manuscript and for your valuable contribution to APAAACI always.
APAAACI Surveys
Our committee leaders and JAAFCA members are continue to be actively involved in developing consensus documents/state of the art review papers and implementation of other initiatives.
Currently we have several surveys in progress namely,
• SURVEY ON HEREDITARY ANGIOEDEMA (HAE)
• SURVEY ON PENICILLIN ALLERGY
• SURVEY ON IGE-MEDIATED FOOD ALLERGY DIAGNOSIS AND MANAGEMENT
Stay tuned for more updates!
APAAACI MasterClass: Severe Allergies: Current Concepts on the Mechanisms & Management Strategies
We are excited to announce our next APAAACI MasterClass, on 11th October 2022, with the theme: Severe Allergies: Current Concepts on the Mechanisms & Management Strategies.
Live simultaneous translation for Chinese delegates will be provided specially for this particular masterclass. Please save the date and look forward for more updates regarding the speaker details and further information.
Registration details below,
Highlights of the Allergy World
Allergic and eosinophilic asthma in the era of biomarkers and biologics: similarities, differences and misconceptions https://www.annallergy.org/article/S1081-1206(22)00170-3/fulltext Oppenheimer J, Hoyte FCL, Phipatanakul W, Silver J, Howarth P, Lugogo NL. Ann Allergy Asthma Immunol. 2022 Aug;129(2):169-180. doi: 10.1016/j.anai.2022.02.021. Epub 2022 Mar 7. PMID: 35272048.
The adverse reactions to vaccines practice parameter 10 years on-what have we learned? https://www.annallergy.org/article/S1081-1206(22)00049-7/fulltext Kelso JM. Ann Allergy Asthma Immunol. 2022 Jul;129(1):35-39. doi: 10.1016/j.anai.2022.01.026. Epub 2022 Jan 31. PMID: 35101646; PMCID: PMC8801260.
Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study Horn MP, Jonsdottir HR, Brigger D, Damonti L, Suter-Riniker F, Endrich O, Froehlich TK, Fiedler M, Largiadèr CR, Marschall J, Weber B, Eggel A, Nagler M. Allergy. 2022 Jul;77(7):2090-2103. doi: 10.1111/all.15206. Epub 2022 Jan 11. PMID: 34986501; PMCID: PMC9303219.
The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update Maurer M, Magerl M, Betschel S, Aberer W, Ansotegui IJ, Aygören-Pürsün E, Banerji A, Bara NA, Boccon-Gibod I, Bork K, Bouillet L, Boysen HB, Brodszki N, Busse PJ, Bygum A, Caballero T, Cancian M, Castaldo A, Cohn DM, Csuka D, Farkas H, Gompels M, Gower R, Grumach AS, Guidos-Fogelbach G, Hide M, Kang HR, Kaplan AP, Katelaris C, Kiani-Alikhan S, Lei WT, Lockey R, Longhurst H, Lumry WR, MacGinnitie A, Malbran A, Martinez Saguer I, Matta JJ, Nast A, Nguyen D, Nieto-Martinez SA, Pawankar R, Peter J, Porebski G, Prior N, Reshef A, Riedl M, Ritchie B, Rafique Sheikh F, Smith WB, Spaeth PJ, Stobiecki M, Toubi E, Varga LA, Weller K, Zanichelli A, Zhi Y, Zuraw B, Craig T. Allergy. 2022 Jul;77(7):1961-1990. doi: 10.1111/all.15214. Epub 2022 Feb 3. PMID: 35006617.
The unfulfilled potential of mucosal immunization https://www.jacionline.org/article/S0091-6749(22)00628-5/fulltext Baker JR Jr, Farazuddin M, Wong PT, O’Konek JJ. J Allergy Clin Immunol. 2022 Jul;150(1):1-11. doi: 10.1016/j.jaci.2022.05.002. Epub 2022 May 13. PMID: 35569567; PMCID: PMC9098804.
Safety of peanut (Arachis hypogaea) allergen powder-dnfp in children and teenagers with peanut allergy: Pooled summary of phase 3 and extension trials https://www.jacionline.org/article/S0091-6749(21)02740-8/fulltext Brown KR, Baker J, Vereda A, Beyer K, Burks AW, du Toit G, O’B Hourihane J, Jones SM, Norval D, Dana A, Shreffler W, Vickery BP, Casale T, Skeel B, Adelman D. J Allergy Clin Immunol. 2022 Jun;149(6):2043-2052.e9. doi: 10.1016/j.jaci.2021.12.780. Epub 2021 Dec 29. PMID: 34971646.
Prevalence of sensitization to molecular food allergens in Europe: A systematic review Lisik D, Ioannidou A, Spolidoro G, Ali M, Nyassi S, Amera Y, Rovner G, Khaleva E, Venter C, van Ree R, Worm M, Vlieg-Boerstra B, Sheikh A, Muraro A, Roberts G, Nwaru BI. Clin Transl Allergy. 2022 Jul 6;12(7):e12175. doi: 10.1002/clt2.12175. PMID: 35821705; PMCID: PMC9260209.
World Health Organization global air quality guideline recommendations: Executive summary Goshua A, Akdis C, Nadeau KC. Allergy 2022; 77: 1955-1960
Risk factors for systemic reactions in typical cold urticaria: Results from the COLD- CE study Bizjak M, Košnik M, Dinevski D, Thomsen SF, Fomina D, Borzova E, et al. Allergy 2022; 77: 2185-2199
Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one-year extension study Maurer M, Giménez-Arnau A, Bernstein JA, Chu CY, Danily cheva I, Hide M, et al. Allergy 2022; 77: 2175-2184
Asia Pacific perspectives on the second year of the COVID-19 pandemic: A follow-up survey Ruby Pawankar, Bernard Yu-Hor Thong, Marysia Tiongco-Recto, Jiu-Yao Wang, Amir Hamzah Abdul Latiff, Ting Fan Leung, et al. Clin Exp Allergy 2022; 52: 965-973
Website Editor: Prof. Bernard Thong
Website Co-Editor: Prof. Amir HA Latiff
APAAACI Journal is the Asia Pacific Allergy Journal: https://www.apallergy.org/
Professor Ruby Pawankar
APAAACI President
